Austin, Texas, United States, December 2nd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said ...

Reframing women’s health care includes a greater emphasis on health span, and a closer look at ovarian aging, according to an ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on dosing, FDA filings and an ...

This piece is part of Letters on Pragmatic Hope, an essay series in which Wesleyan professors and administrators reflect on a daunting question: How can students act with purpose and efficacy amid an ...

The US Federal Reserve said it was cutting rates by 25 basis points to target 3.5 to 3.75 percent, despite high ...

Learn the nine key warning signs that may indicate it’s time for a depression screening. Understand when low mood, fatigue, or changes in sleep could signal something more serious.

The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...

Flow is a transcranial direct current stimulation device that delivers low-intensity direct electrical current to specific areas of the brain.

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

PITTSBURGH, Nov. 21, 2025 /PRNewswire/ -- An inventor from Pembroke Pines, FL, who works as a mental health medical provider, has developed an innovative tool designed to help individuals track and ...

Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...